Sustainable business behaviour is of great importance in the pharma industry. Clients of CDMOs want it in-house but also want to see in their partners. Without it, the supply chain can easily suffer, and this subject has been the topic of a lively discussion in recent months for obvious reasons. One pillar of sustainability are sound environmental protection practices. This webinar presents these aspects in a general way, in the context of the environmental protection developments in China and shows how the subject is managed by Raybow.
PresentersDr. Dirk Hütten moderates with Dr. Andreas Flueckiger presenting.
Dirk HüttenSenior Director Business DevelopmentRaybow Pharmaceutical
Dr. Dirk Hütten holds a PhD in Chemistry from the University of Cologne, Germany. He has more than 20 years of experience in global sales and marketing alongside the supply chain of pharmaceuticals and APIs including positions at GSK, Altana and PharmaZell. In 2019, he joined Raybow Pharmaceutical as Senior Director Business Development. In addition, Dirk is passionate about high performance sailing.
Andreas Flueckiger is a specialist in internal and in occupational medicine. He was the Global Head of Occupational Health and Occupational Toxicology of one of the world’s top three pharmaceutical companies for >30 years. During this time, he and his department set over 2000 limits values for APIs, synthesis intermediates and other chemicals. As these limits are a determinant for the engineering controls necessary to safely handle these molecules, he has gained ample expertise in containment solutions and industrial hygiene assessments at the workplaces and related GMP matters.